About DF/HCC

Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated comprehensive cancer center, was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community. Five Boston academic medical institutions—Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital—and two Harvard Schools—the Harvard Medical School and the Harvard T.H. Chan School of Public Health—combined their scientific strengths to create a rich, collaborative environment that transcends institutional borders. DF/HCC is the powerful successor organization to the Dana-Farber Cancer Institute Comprehensive Cancer Center, one of the original cancer centers designated by the NCI in 1973.

Today, more than 1,100 DF/HCC cancer researchers are working together in innovative clinical-, translational-, basic-, and population-based research programs. Our members receive in excess of $600 million in cancer research funding. Cost-effective shared facilities, or centralized core laboratories, enable access to cutting edge technologies and allow us to build world-class scientific archives. Our members are training and educating the next generation of cancer researchers. Thousands of patients are being enrolled in our clinical trials. 

As one of the largest cancer research enterprises in the world, DF/HCC is committed to maximizing the impact of its research for cancer patients and ultimately realizing a world without cancer.

    Breast Cancer

    Cancer Care Delivery Research

    Cancer Cell Biology

    Cancer Data Sciences

    Cancer Epidemiology

    Cancer Genetics and Epigenetics

    Cancer Immunology

    Cancer Risk, Prevention, and Early Detection

    Developmental Therapeutics

    Gastrointestinal Malignancies

    Gynecologic Cancers

    Kidney Cancer


    Lung Cancer

    Lymphoma and Myeloma



    Prostate Cancer


    Deborah Goff, PhD

    Vice President, DF/HCC Administration(617) 632-4044EMAIL
    Amanda SmithExecutive Assistant for Ramesh Shivdasani(617) 632-3487EMAIL
    Mark Grinstein-CamachoDF/HCC Administrative Specialist EMAIL


    Richard OakleyCommunications Director(617) 632-4276EMAIL

    Core Facilities

    Michelle CoxSenior Director for Core Facilities(617) 632-3566EMAIL
    Kelly SmithProgram Manager(617) 632-4104EMAIL


    Thomas LeonardWeb Systems Architect(617) 632-3937EMAIL

    Initiative to Eliminate Cancer Disparities

    Karen Burns WhiteDeputy Associate Director(617) 632-3244EMAIL
    Brittany MichelProgram Manager EMAIL
    Julia MillerProgram Manager EMAIL

    Membership, Program Coordination, and Operations

    Jun-Rong Wei, PhDDirector, DFHCC Operations EMAIL
    Jackie HwangProgram Manager(617) 632-5685EMAIL
    Erica FletcherGrant Administrator(617) 632-4864EMAIL

    For clinical trials administration contact information, visit the Clinical Research section.